Alk-Abello ASWBO:ALKB -0.12%66 Dividend Yield % is 0.63% as of Jun. 26, 2026, which is 19% above its 10-year median of 0.53. GuruFocus rates WBO:ALKB with a GF Score™ of 66/100 and a GF Value™ of €27.26 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 151 Biotechnology companies, Alk-Abello AS ranks worse than 76.16% on this metric.
As of today (2026-06-26), the Trailing Annual Dividend Yield of Alk-Abello AS is 0.63%.
Warning Sign:
Alk-Abello AS stock Dividend Yield % is close to 5-year low.
The historical rank and industry rank for Alk-Abello AS's Dividend Yield % or its related term are showing as below:
WBO:ALKB'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.42 Med: 0.53 Max: 0.78
Current: 0.63
During the past 13 years, the highest Dividend Yield of Alk-Abello AS was 0.78%. The lowest was 0.42%. And the median was 0.53%.
WBO:ALKB's Dividend Yield % is ranked worse than 76.16% of 151
companies
in the Biotechnology industry
Industry Median: 1.53
vs WBO:ALKB: 0.63
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Alk-Abello AS was 154.60% per year. The lowest was -70.80% per year. And the median was 0.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Alk-Abello AS (WBO:ALKB) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Alk-Abello AS's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:ALKB vs VRTX, REGN, ALNY: Dividend Yield % Comparison
For the Biotechnology subindustry, Alk-Abello AS's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alk-Abello AS Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alk-Abello AS's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Alk-Abello AS's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Alk-Abello AS Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
DKK 1.600000
2026-03-17
2026-03-18
2026-03-19
Cash Dividend
annually
DKK:EUR 0.133360
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Alk-Abello AS's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.213376
/
34.22
=
0.62 %
Current Share Price is €34.22. Alk-Abello AS's Dividends per Share for the trailing twelve months (TTM) ended in Today is €0.213376.
Alk-Abello AS's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.213376
/
34.22
=
0.62 %
Current Share Price is €34.22. Alk-Abello AS's Dividends per Share for the forward twelve months is calculated as €0.213376 * 1 = €0.213376.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alk-Abello AS (WBO:ALKB) has a Dividend Yield % of 0.63% as of Jun. 26, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Alk-Abello AS and its competitors. This is 19% above median its historical median of 0.53. Over the past decade, Alk-Abello AS's Dividend Yield % has ranged from 0.42 to 0.78. According to the industry distribution chart, Alk-Abello AS ranks #115 out of 151 companies in the Biotechnology industry, placing it in the top 76.2%.
Is Alk-Abello AS's Dividend Yield % too high?
Alk-Abello AS's current Dividend Yield % of 0.63% is 19% above median its 10-year median of 0.53. Over the past 10 years, this metric has ranged from a low of 0.42 to a high of 0.78. The Biotechnology industry median Dividend Yield % is 1.53. Alk-Abello AS's value of 0.63% is 58.8% below this industry median. Based on the distribution chart, Alk-Abello AS ranks #115 out of 151 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Alk-Abello AS has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alk-Abello AS's Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Alk-Abello AS ranks #115 out of 151 companies for Dividend Yield %. This places Alk-Abello AS in the lower half of its industry. The industry median Dividend Yield % is 1.53. Alk-Abello AS's value of 0.63% is 58.8% below this benchmark. Historically, Alk-Abello AS's own Dividend Yield % has ranged from 0.42 to 0.78 over the past decade. While the company's 10-year median is 0.53 vs. the industry median of 1.53, Alk-Abello AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.53, based on 151 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alk-Abello AS's current Dividend Yield % of 0.63% is 58.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Alk-Abello AS and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alk-Abello AS's current Dividend Yield % is 0.63%, which is 19% above median its own 10-year median of 0.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alk-Abello AS stock overvalued right now?
Based on GuruFocus' analysis, Alk-Abello AS (WBO:ALKB) is currently considered Modestly Overvalued. The stock's GF Value™ is €27.26, compared to a current price of €34.22 — trading 25.5% above its estimated fair value. The current Dividend Yield % is 0.63%, which is 19% above median its 10-year median of 0.53 and 58.8% below the Biotechnology industry median of 1.53. Alk-Abello AS's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Alk-Abello AS (WBO:ALKB), the current Dividend Yield % is 0.63% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alk-Abello AS (WBO:ALKB) Overvalued in 2026?
Based on GuruFocus' analysis, Alk-Abello AS stock appears to be overvalued.
The current stock price of €34.22 is trading 25.5% above its estimated GF Value™ of €27.26.
GuruFocus considers Alk-Abello AS to be Modestly Overvalued.
Key valuation signals for WBO:ALKB:
Dividend Yield %: 0.63% (19% above median its 10-year median of 0.53)
GF Value™: €27.26 vs. price of €34.22 (25.5% above fair value)
Industry Position: 58.8% below the Biotechnology median (#115 of 151)
No single metric tells the full story. See the WBO:ALKB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
66GF Score
Get the complete analysis for WBO:ALKB
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:ALKB has been successfully added to your 
